Recombinant Human LIF 0 ReviewsSubmit a Review Product Details Catalogue Number: 300-05 Description: LIF is a pleiotrophic factor produced by multiple cell types, including T cells, myelomonocytic lineages, fibroblasts, liver, heart and melanoma. LIF promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Other activities include the stimulation of acute phase protein synthesis by hepatocytes, stimulation of differentiation of cholinergic nerves, and suppression of adipogenesis by inhibiting the lipoprotein lipase in adipocytes. While human LIF is active on mouse cells and is widely used in the maintenance of murine ESC to prevent spontaneous differentiation, mouse LIF is not active on human cells due to its inability to bind to the human LIF receptor. Recombinant Human LIF is a 19.7 kDa protein containing 180 amino acid residues, including three disulfide bonds. Source: E.coli Synonyms: Leukemia Inhibitory Factor, Differentiation-stimulating factor, D factor, Melanoma-derived LPL inhibitor (MLPLI), Interleukin 6 family cytokine AA Sequence: SPLPITPVNA TCAIRHPCHN NLMNQIRSQL AQLNGSANAL FILYYTAQGE PFPNNLDKLC GPNVTDFPPF HANGTEKAKL VELYRIVVYL GTSLGNITRD QKILNPSALS LHSKLNATAD ILRGLLSNVL CRLCSKYHVG HVDVTYGPDT SGKDVFQKKK LGCQLLGKYK QIIAVLAQAF Purity: ≥ 98% by SDS-PAGE gel and HPLC analyses. Biological Activity: Determined by its ability to stimulate the proliferation of human TF-1 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 107 units/mg. This product has been tested against the WHO standard. International Unit information can be found here. Calculated Molecular Weight: 19.7 kDa Accession Number: P15018 Gene ID: 3976 crossreactivity: Human, Mouse, Pig, Rat References PubMed SDS CoA Search Product Line Country Of Origin: USA Not for human use. Research Interest Diabetes/Weight Regulation Immune System Lipid Metabolism Neurobiology Stem Cells & Differentiation product.subtitle.recentcitations First Author Szczerbinska, I Title A Chemically Defined Feeder-free System for the Establishment and Maintenance of the Human Naive Pluripotent State. Citation Stem Cell Reports; 13(4) pg612-626 PubMed Id 31522974 First Author Haag, D Title H3.3-K27M drives neural stem cell-specific gliomagenesis in a human iPSC-derived model. Citation Cancer Cell; 39(3) pg407-422.e13 PubMed Id 33545065 First Author Traer, E Title Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations. Citation Blood; 123(10) pg1516-24 PubMed Id 24408322
